Additionally, specific diarylheptanoids were reported to suppress proliferation of pancreatic cancer cells through modulating Hh-GLI-FOXM1 pathway [51], indicating a promising approach to blockade Hh-GLI-FOXM1 signal axis specifically. Here, FOXM1 is linked to pancreatic neoplasm.